Aion Therapeutic Inc.

OTCPK:ANTC.F Stock Report

Market Cap: US$5.1m

Aion Therapeutic Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

John Simmonds

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has John Simmonds's remuneration changed compared to Aion Therapeutic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$6m

Apr 30 2024n/an/a

-CA$6m

Jan 31 2024n/an/a

-CA$1m

Oct 31 2023n/an/a

-CA$934k

Jul 31 2023n/an/a

-CA$879k

Apr 30 2023n/an/a

-CA$257k

Jan 31 2023n/an/a

-CA$2m

Oct 31 2022n/an/a

-CA$2m

Jul 31 2022n/an/a

-CA$3m

Apr 30 2022n/an/a

-CA$4m

Jan 31 2022n/an/a

-CA$7m

Oct 31 2021n/an/a

-CA$8m

Jul 31 2021n/an/a

-CA$8m

Apr 30 2021n/an/a

-CA$8m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$2m

Jul 31 2020n/an/a

-CA$660k

Apr 30 2020CA$23kCA$23k

-CA$673k

Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.


CEO

John Simmonds (50 yo)

4.8yrs

Tenure

CA$22,500

Compensation

Mr. John Graham Simmonds, Jr., has been the Chief Executive Officer of Gilla Inc. since November 15, 2012. Mr. Simmonds is the Founder of Baymount Incorp., and has been its Chief Executive Officer since Se...